Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd [2020] FCA 1530

Allergan Australia Pty Ltd v Self Care IP Holdings Pty Ltd [2020] FCA 1530

Self Care's use of 'PROTOX' and composite phrases such as 'Botox alternative' did not infringe Allergan's BOTOX trade marks as they were not used as trade marks indicating origin, were not deceptively similar, and did not amount to misleading or deceptive conduct or passing off because the statements (in context) represented the products as alternatives and not as affiliated/same as Allergan's. Only one efficacy statement (that Night (tube) delivers Botox results in 4 weeks) was found misleading. Allergan's BOTOX class 3 mark (655 mark) was ordered removed for non-use, but the 426 defensive mark was upheld. The appeal against registration of FREEZEFRAME PROTOX failed as the mark was not...

Jurisdiction
Australia
Judgment Date
22 October 2020
Procedural Posture
Trial and Appeal / Judgment (first Instance and Appeal From the Trade Marks Office)
Outcome
Allergan's claims largely dismissed; one ACL claim (re: Night (tube) statement) upheld; Self Care's cross-claim (re: class 3, 655 mark) successful; Allergan's appeal against FREEZEFRAME PROTOX registration dismissed.
Legal Topics
['trade Marks' 'passing Off' 'misleading or Deceptive Conduct' 'defensive Trade Marks' 'rectification/removal of Trade Mark' 'personal Liability of Directors']
['intellectual Property' 'consumer Law' 'torts'] ['trade Marks' 'passing Off' 'misleading or Deceptive Conduct' 'defensive Trade Marks' 'rectification/removal of Trade Mark' 'personal Liability of Directors']

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Trial and Appeal / Judgment (first Instance and Appeal From the Trade Marks Office)

Legal Issues

  1. 1 ["Whether Self Care's use of PROTOX and composite phrases infringed Allergan's BOTOX trade marks under Trade Marks Act 1995 (Cth) s 120." 'Whether Self Care made misleading or deceptive representations in contravention of the Australian Consumer Law about affiliation with or efficacy compared with BOTOX.' "Whether Self Care's conduct amounted to passing off." "Whether certain BOTOX trade marks were liable for removal or cancellation on grounds including non-use or lack of 'defensive' character for class 3 goods." 'Whether the Trade Mark Office erred in allowing registration of the FREEZEFRAME PROTOX mark.']

Ratio Decidendi

Self Care's use of 'PROTOX' and composite phrases such as 'Botox alternative' did not infringe Allergan's BOTOX trade marks as they were not used as trade marks indicating origin, were not deceptively similar, and did not amount to misleading or deceptive conduct or passing off because the statements (in context) represented the products as alternatives and not as affiliated/same as Allergan's. Only one efficacy statement (that Night (tube) delivers Botox results in 4 weeks) was found misleading. Allergan's BOTOX class 3 mark (655 mark) was ordered removed for non-use, but the 426 defensive mark was upheld. The appeal against registration of FREEZEFRAME PROTOX failed as the mark was not...

Court Disposition

Allergan's claims largely dismissed; one ACL claim (re: Night (tube) statement) upheld; Self Care's cross-claim (re: class 3, 655 mark) successful; Allergan's appeal against FREEZEFRAME PROTOX registration dismissed.

Orders

  • ['Parties to bring draft orders regarding disposition, costs, and publication/redactions within 14 days (NSD 15 of 2017).' 'Text of reasons temporarily restricted to lawyers; subject to later publication.' 'In NSD 1802 of 2017, appeal dismissed, costs to respondent, time for further appeal extended pending final...